Laporan Laba Rugi (TTM)
Laporan Laba Rugi Ilyang Pharmaceutical Co.,Ltd - Preferred Stock menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 336,954 | 343,329 | 353,771 | 353,265 | 351,562 | 242,512 | 246,121 | 247,702 | 260,618 | 247,773 | 242,399 | 244,616 | 231,394 | 266,669 | 245,071 | 218,181 | 216,690 | 268,861 | 272,120 | 276,352 |
| Change (%) | 1.89 | 3.04 | -0.14 | -0.48 | -31.02 | 1.49 | 0.64 | 5.21 | -4.93 | -2.17 | 0.91 | -5.41 | 15.24 | -8.10 | -10.97 | -0.68 | 24.08 | 1.21 | 1.56 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 158,607 | 161,690 | 166,040 | 166,891 | 159,422 | 137,865 | 136,245 | 132,468 | 139,152 | 139,579 | 142,794 | 146,079 | 140,049 | 150,266 | 145,237 | 143,470 | 140,643 | 157,461 | 157,812 | 160,471 |
| Change (%) | 1.94 | 2.69 | 0.51 | -4.48 | -13.52 | -1.17 | -2.77 | 5.05 | 0.31 | 2.30 | 2.30 | -4.13 | 7.29 | -3.35 | -1.22 | -1.97 | 11.96 | 0.22 | 1.68 | |
| % of Revenue | 47.07 | 47.09 | 46.93 | 47.24 | 45.35 | 56.85 | 55.36 | 53.48 | 53.39 | 56.33 | 58.91 | 59.72 | 60.52 | 56.35 | 59.26 | 65.76 | 64.91 | 58.57 | 57.99 | 58.07 |
| Gross Operating Profit | 178,346 | 181,638 | 187,731 | 186,374 | 192,140 | 104,646 | 109,876 | 115,235 | 121,466 | 108,194 | 99,605 | 98,538 | 91,345 | 116,404 | 99,834 | 74,710 | 76,047 | 111,400 | 114,308 | 115,882 |
| Change (%) | 1.85 | 3.35 | -0.72 | 3.09 | -45.54 | 5.00 | 4.88 | 5.41 | -10.93 | -7.94 | -1.07 | -7.30 | 27.43 | -14.23 | -25.17 | 1.79 | 46.49 | 2.61 | 1.38 | |
| % of Revenue | 52.93 | 52.91 | 53.07 | 52.76 | 54.65 | 43.15 | 44.64 | 46.52 | 46.61 | 43.67 | 41.09 | 40.28 | 39.48 | 43.65 | 40.74 | 34.24 | 35.09 | 41.43 | 42.01 | 41.93 |
| SG&A | 123,825 | 124,820 | 130,575 | 130,360 | 135,128 | 70,212 | 70,516 | 72,959 | 76,233 | 68,641 | 65,897 | 68,109 | 66,214 | 73,211 | 59,325 | 39,048 | 40,054 | 72,660 | 74,771 | 75,607 |
| Change (%) | 0.80 | 4.61 | -0.16 | 3.66 | -48.04 | 0.43 | 3.46 | 4.49 | -9.96 | -4.00 | 3.36 | -2.78 | 10.57 | -18.97 | -34.18 | 2.58 | 81.41 | 2.91 | 1.12 | |
| % of Revenue | 36.75 | 36.36 | 36.91 | 36.90 | 38.44 | 28.95 | 28.65 | 29.45 | 29.25 | 27.70 | 27.19 | 27.84 | 28.62 | 27.45 | 24.21 | 17.90 | 18.48 | 27.03 | 27.48 | 27.36 |
| R&D | 19,832 | 19,723 | 18,719 | 18,822 | 18,647 | 16,829 | 18,643 | 19,035 | 21,369 | 22,395 | 23,226 | 24,886 | 24,541 | 23,748 | 23,564 | 21,396 | 24,023 | 24,740 | 24,267 | 25,018 |
| Change (%) | -0.55 | -5.09 | 0.55 | -0.93 | -9.75 | 10.78 | 2.10 | 12.26 | 4.80 | 3.71 | 7.14 | -1.38 | -3.23 | -0.78 | -9.20 | 12.28 | 2.98 | -1.91 | 3.10 | |
| % of Revenue | 5.89 | 5.74 | 5.29 | 5.33 | 5.30 | 6.94 | 7.57 | 7.68 | 8.20 | 9.04 | 9.58 | 10.17 | 10.61 | 8.91 | 9.62 | 9.81 | 11.09 | 9.20 | 8.92 | 9.05 |
| OpEx | 305,070 | 309,228 | 318,291 | 319,158 | 316,360 | 227,323 | 227,894 | 226,862 | 239,249 | 233,524 | 234,927 | 243,056 | 234,910 | 250,290 | 231,118 | 205,989 | 206,946 | 257,861 | 259,793 | 263,966 |
| Change (%) | 1.36 | 2.93 | 0.27 | -0.88 | -28.14 | 0.25 | -0.45 | 5.46 | -2.39 | 0.60 | 3.46 | -3.35 | 6.55 | -7.66 | -10.87 | 0.46 | 24.60 | 0.75 | 1.61 | |
| % of Revenue | 90.54 | 90.07 | 89.97 | 90.35 | 89.99 | 93.74 | 92.59 | 91.59 | 91.80 | 94.25 | 96.92 | 99.36 | 101.52 | 93.86 | 94.31 | 94.41 | 95.50 | 95.91 | 95.47 | 95.52 |
| Operating Income | 31,884 | 34,101 | 35,480 | 34,107 | 35,202 | 15,188 | 18,227 | 20,841 | 21,369 | 14,249 | 7,472 | 1,560 | -3,516 | 16,379 | 13,953 | 12,192 | 9,745 | 11,000 | 12,327 | 12,386 |
| Change (%) | 6.95 | 4.05 | -3.87 | 3.21 | -56.85 | 20.01 | 14.34 | 2.53 | -33.32 | -47.56 | -79.12 | -325.35 | -565.82 | -14.81 | -12.62 | -20.07 | 12.89 | 12.06 | 0.48 | |
| % of Revenue | 9.46 | 9.93 | 10.03 | 9.65 | 10.01 | 6.26 | 7.41 | 8.41 | 8.20 | 5.75 | 3.08 | 0.64 | -1.52 | 6.14 | 5.69 | 5.59 | 4.50 | 4.09 | 4.53 | 4.48 |
| Interest Expense | -3,427 | -3,017 | -2,369 | -2,122 | -2,122 | -1,894 | -1,877 | -2,035 | -2,035 | -2,132 | -2,924 | -3,487 | -3,487 | -3,225 | -2,863 | -1,854 | -1,854 | -2,932 | -3,051 | -3,051 |
| Change (%) | -11.97 | -21.48 | -10.42 | -0.00 | -10.73 | -0.88 | 8.41 | -0.00 | 4.75 | 37.13 | 19.28 | -0.00 | -7.51 | -11.22 | -35.24 | -0.00 | 58.09 | 4.06 | -0.00 | |
| % of Revenue | -1.02 | -0.88 | -0.67 | -0.60 | -0.60 | -0.78 | -0.76 | -0.82 | -0.78 | -0.86 | -1.21 | -1.43 | -1.51 | -1.21 | -1.17 | -0.85 | -0.86 | -1.09 | -1.12 | -1.10 |
| Net Income | 10,558 | 10,880 | 8,045 | 8,727 | 11,559 | 14,032 | 19,658 | 20,882 | 20,909 | 19,385 | 16,275 | 9,031 | 6,102 | -2,409 | -3,469 | 505 | -874 | 10,257 | 11,940 | 11,457 |
| Change (%) | 3.04 | -26.06 | 8.48 | 32.46 | 21.39 | 40.09 | 6.23 | 0.13 | -7.29 | -16.04 | -44.51 | -32.43 | -139.47 | 44.00 | -114.56 | -273.14 | -1,273.21 | 16.41 | -4.05 | |
| % of Revenue | 3.13 | 3.17 | 2.27 | 2.47 | 3.29 | 5.79 | 7.99 | 8.43 | 8.02 | 7.82 | 6.71 | 3.69 | 2.64 | -0.90 | -1.42 | 0.23 | -0.40 | 3.82 | 4.39 | 4.15 |
Source: Capital IQ
